1. Home
  2. IMRX vs ONCH Comparison

IMRX vs ONCH Comparison

Compare IMRX & ONCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRX
  • ONCH
  • Stock Information
  • Founded
  • IMRX 2008
  • ONCH 2024
  • Country
  • IMRX United States
  • ONCH United States
  • Employees
  • IMRX N/A
  • ONCH N/A
  • Industry
  • IMRX Biotechnology: Pharmaceutical Preparations
  • ONCH
  • Sector
  • IMRX Health Care
  • ONCH
  • Exchange
  • IMRX Nasdaq
  • ONCH Nasdaq
  • Market Cap
  • IMRX 232.9M
  • ONCH 223.4M
  • IPO Year
  • IMRX 2021
  • ONCH 2025
  • Fundamental
  • Price
  • IMRX $7.49
  • ONCH $10.27
  • Analyst Decision
  • IMRX Strong Buy
  • ONCH
  • Analyst Count
  • IMRX 5
  • ONCH 0
  • Target Price
  • IMRX $17.20
  • ONCH N/A
  • AVG Volume (30 Days)
  • IMRX 1.2M
  • ONCH 39.1K
  • Earning Date
  • IMRX 11-12-2025
  • ONCH 01-01-0001
  • Dividend Yield
  • IMRX N/A
  • ONCH N/A
  • EPS Growth
  • IMRX N/A
  • ONCH N/A
  • EPS
  • IMRX N/A
  • ONCH N/A
  • Revenue
  • IMRX N/A
  • ONCH N/A
  • Revenue This Year
  • IMRX N/A
  • ONCH N/A
  • Revenue Next Year
  • IMRX N/A
  • ONCH N/A
  • P/E Ratio
  • IMRX N/A
  • ONCH N/A
  • Revenue Growth
  • IMRX N/A
  • ONCH N/A
  • 52 Week Low
  • IMRX $1.10
  • ONCH $10.18
  • 52 Week High
  • IMRX $10.08
  • ONCH $10.63
  • Technical
  • Relative Strength Index (RSI)
  • IMRX 62.47
  • ONCH N/A
  • Support Level
  • IMRX $6.62
  • ONCH N/A
  • Resistance Level
  • IMRX $7.50
  • ONCH N/A
  • Average True Range (ATR)
  • IMRX 0.62
  • ONCH 0.00
  • MACD
  • IMRX 0.08
  • ONCH 0.00
  • Stochastic Oscillator
  • IMRX 91.19
  • ONCH 0.00

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

About ONCH 1RT Acquisition Corp. Class A Ordinary Share

1RT Acquisition Corp is a blank check company.

Share on Social Networks: